Please assess the completion status of the following clinical trial:

Trial Title: Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Patients with locally advanced breast cancer (cT3-4c, N0-3) with tumors \> 5 cm, as determined by MRI, where the present guidelines include them for neoadjuvant systemic therapy~* Written informed consent (informed consent document to be approved by the Independent Ethics Committee) prior to study-related procedures and examinations.~* Female age \> 18 years~* Able to comply with the protocol~* Histologically confirmed adenocarcinoma of the breast~* American Society of Anesthesiologist's physical status category 1 or 2 before surgery. Category 1 and 2 includes healthy patients and patients with only mild systemic disease, whereas category 3 includes patients with more serious systemic diseases (but still operable).~Exclusion criteria:~* Inflammatory breast cancer or diffuse locoregional involvement of the skin~* Stage IV - metastatic disease~* Locoregional relapse of earlier breast cancer~* Inability (irrespective of reason) to receive the recommended neoadjuvant treatment, - as decided by the treating physician.~* American Society of Anesthesiologist's physical status category 4-5

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).